PD-L1 expression in GBM was previously reported to be highly variable between patients.51 This observation was confirmed in our panel of low-passage patient-derived GBM cultures, with PD-L1 expression varying from 1% to 87% positive cells. The gene discussed is CD274; the disease is glioblastoma.